| For: | Cheng Y, Dharancy S, Malapel M, Desreumaux P. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor α and carnitine palmitoyl acyl-CoA transferase 1A. World J Gastroenterol 2005; 11(48): 7591-7596 [PMID: 16437683 DOI: 10.3748/wjg.v11.i48.7591] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i48/7591.htm |
| Number | Citing Articles |
| 1 |
Nirmal Mazumder, Rodney K. Lyn, Ragunath Singaravelu, Andrew Ridsdale, Douglas J. Moffatt, Chih-Wei Hu, Han-Ruei Tsai, John McLauchlan, Albert Stolow, Fu-Jen Kao, John Paul Pezacki, Ravi Jhaveri. Fluorescence Lifetime Imaging of Alterations to Cellular Metabolism by Domain 2 of the Hepatitis C Virus Core Protein. PLoS ONE 2013; 8(6) doi: 10.1371/journal.pone.0066738
|
| 2 |
Shaikh Mizanoor Rahman, Ishtiaq Qadri, Rachel C. Janssen, Jacob E. Friedman. Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis. Journal of Lipid Research 2009; 50(11) doi: 10.1194/jlr.M800633-JLR200
|
| 3 |
Elisabetta Bugianesi, Federico Salamone, Francesco Negro. The interaction of metabolic factors with HCV infection: Does it matter?. Journal of Hepatology 2012; 56 doi: 10.1016/S0168-8278(12)60007-5
|
| 4 |
Doaa I. Mohamed, Ahmed A.M. Elmelegy, Lubna F.A. El-Aziz, Hala S. Abdel kawy, Abeer A. Abd El-Samad, Omnyah A. El-Kharashi. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats. European Journal of Pharmacology 2013; 721(1-3) doi: 10.1016/j.ejphar.2013.09.058
|
| 5 |
Birke Bartosch, Robert Thimme, Hubert E. Blum, Fabien Zoulim. Hepatitis C virus-induced hepatocarcinogenesis. Journal of Hepatology 2009; 51(4) doi: 10.1016/j.jhep.2009.05.008
|
| 6 |
Mariana V. Machado, Helena Cortez-Pinto. Insulin resistance and steatosis in chronic hepatitis C. Annals of Hepatology 2009; 8 doi: 10.1016/S1665-2681(19)31829-0
|
| 7 |
Qing Liu, Stig Bengmark, Shen Qu. Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis. BMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-49
|
| 8 |
Valerio Pazienza, Manlio Vinciguerra, Gianluigi Mazzoccoli. PPARs Signaling and Cancer in the Gastrointestinal System. PPAR Research 2012; 2012 doi: 10.1155/2012/560846
|
| 9 |
M. Eslam, M. A. Khattab, S. A. Harrison. Peroxisome proliferator-activated receptors and hepatitis C virus. Therapeutic Advances in Gastroenterology 2011; 4(6) doi: 10.1177/1756283X11405251
|
| 10 |
Jonathan Goldwasser, Pazit Y. Cohen, Wenyu Lin, Danny Kitsberg, Patrick Balaguer, Stephen J. Polyak, Raymond T. Chung, Martin L. Yarmush, Yaakov Nahmias. Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. Journal of Hepatology 2011; 55(5) doi: 10.1016/j.jhep.2011.02.011
|
| 11 |
Kohichiroh Yasui, Yuichi Harano, Hironori Mitsuyoshi, Kazuhiro Tsuji, Mio Endo, Tomoaki Nakajima, Masahito Minami, Yoshito Itoh, Yoh Zen, Yasuni Nakanuma, Toshikazu Yoshikawa, Takeshi Okanoue. Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus. Journal of Gastroenterology 2010; 45(1) doi: 10.1007/s00535-009-0133-8
|
| 12 |
Annalisa Cespiati, Salvatore Petta, Rosa Lombardi, Vito Di Marco, Vincenza Calvaruso, Cristina Bertelli, Giuseppina Pisano, Erika Fatta, Giordano Sigon, Federica Iuculano, Luciano Crapanzano, Gerlando Gibilaro, Paolo Francione, Antonio Craxì, Silvia Fargion, Anna Ludovica Fracanzani. Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP). Digestive and Liver Disease 2021; 53(10) doi: 10.1016/j.dld.2020.11.001
|
| 13 |
|
| 14 |
Nadine Ahmed, Noreen Ahmed, Roxana Filip, John Paul Pezacki. Nuclear Receptors. 2021; doi: 10.1007/978-3-030-78315-0_13
|
| 15 |
Kerry–Lee Milner, David van der Poorten, Michael Trenell, Arthur B. Jenkins, Aimin Xu, George Smythe, Gregory J. Dore, Amany Zekry, Martin Weltman, Vincent Fragomeli, Jacob George, Donald J. Chisholm. Chronic Hepatitis C Is Associated With Peripheral Rather Than Hepatic Insulin Resistance. Gastroenterology 2010; 138(3) doi: 10.1053/j.gastro.2009.11.050
|
| 16 |
Kaori Yamamoto, Yuka Sasakawa, Fumiko Nakaoka, Mayumi Nakao, Miki Nakamura, Akari Kominami, Michiyo Abe, Chizuko Fukuhama, Kyoichi Kagawa. Effect of globin digest on the liver injury and hepatic gene expression profile in galactosamine-induced liver injury in SD rats. Life Sciences 2011; 88(15-16) doi: 10.1016/j.lfs.2011.02.009
|
| 17 |
Raouia ElFihry, Mohcine Elmessaoudi-Idrissi, Fatima-Zahra Jadid, Imane Zaidane, Hajar Chihab, Mohamed Tahiri, Mostafa Kabine, Wafaa Badre, Isabelle Chemin, Agnes Marchio, Pascal Pineau, Sayeh Ezzikouri, Soumaya Benjelloun. Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients. Virologica Sinica 2020; 35(5) doi: 10.1007/s12250-020-00220-7
|
| 18 |
Charlène Brault, Pierre Levy, Birke Bartosch. Hepatitis C Virus-Induced Mitochondrial Dysfunctions. Viruses 2013; 5(3) doi: 10.3390/v5030954
|
| 19 |
Claudia Vasallo, Pablo Gastaminza. Cellular stress responses in hepatitis C virus infection: Mastering a two-edged sword. Virus Research 2015; 209 doi: 10.1016/j.virusres.2015.03.013
|
| 20 |
Sophie Clément, Francesco Negro. Hepatitis C virus: The viral way to fatty liver. Journal of Hepatology 2007; 46(6) doi: 10.1016/j.jhep.2007.03.005
|
| 21 |
Yoko Tsukuda, Goki Suda, Seiji Tsunematsu, Jun Ito, Fumiyuki Sato, Katsumi Terashita, Masato Nakai, Takuya Sho, Osamu Maehara, Tomoe Shimazaki, Megumi Kimura, Kenichi Morikawa, Mitsuteru Natsuizaka, Koji Ogawa, Shunsuke Ohnishi, Makoto Chuma, Naoya Sakamoto. Anti-adipogenic and antiviral effects ofl-carnitine on hepatitis C virus infection. Journal of Medical Virology 2017; 89(5) doi: 10.1002/jmv.24692
|
| 22 |
Sophie Clément, Stéphanie Pascarella, Francesco Negro. Hepatitis C Virus Infection: Molecular Pathways to Steatosis, Insulin Resistance and Oxidative Stress. Viruses 2009; 1(2) doi: 10.3390/v1020126
|
| 23 |
Mahwish Khan, Shah Jahan, Saba Khaliq, Bushra Ijaz, Waqar Ahmad, Baila Samreen, Sajida Hassan. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. Archives of Virology 2010; 155(11) doi: 10.1007/s00705-010-0797-7
|
| 24 |
Mario Congiu, Marno C. Ryan, Paul V. Desmond. No increase in the expression of key unfolded protein response genes in HCV genotype 3 patients with severe steatosis. Virus Research 2011; 160(1-2) doi: 10.1016/j.virusres.2011.06.019
|
| 25 |
Austin Chan, Keyur Patel, Susanna Naggie. Genotype 3 Infection: The Last Stand of Hepatitis C Virus. Drugs 2017; 77(2) doi: 10.1007/s40265-016-0685-x
|
| 26 |
Candice Jackel-Cram, Lorne A. Babiuk, Qiang Liu. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: Genotype-3a core has a stronger effect than genotype-1b core. Journal of Hepatology 2007; 46(6) doi: 10.1016/j.jhep.2006.10.019
|
| 27 |
Sander Kersten, Rinke Stienstra. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. Biochimie 2017; 136 doi: 10.1016/j.biochi.2016.12.019
|
| 28 |
Ji Ho Suh, Kang Ho Kim, Margaret E. Conner, David D. Moore, Geoffrey A. Preidis. Hepatic PPARα Is Destabilized by SIRT1 Deacetylase in Undernourished Male Mice. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.831879
|
| 29 |
Lakshmi Gopinathan, Daniel B. Hannon, Russell W. Smith, Jeffrey M. Peters, John P. Vanden Heuvel, Wei Xu. Regulation of Peroxisome Proliferator‐Activated Receptors by E6‐Associated Protein. PPAR Research 2008; 2008(1) doi: 10.1155/2008/746935
|
| 30 |
Wen-Yang Li, Yuan Liu, Chen-Fang Gao, Xian-Yong Lan, Xian-Feng Wu. A novel duplicated insertion/deletion (InDel) of the CPT1a gene and its effects on growth traits in goat. Animal Biotechnology 2021; 32(3) doi: 10.1080/10495398.2019.1698433
|
| 31 |
M. Alaei, F. Negro. Hepatitis C virus and glucose and lipid metabolism. Diabetes & Metabolism 2008; 34(6) doi: 10.1016/S1262-3636(08)74606-8
|
| 32 |
M. C. Ryan, P. V. Desmond, J. L. Slavin, M. Congiu. Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver. Journal of Viral Hepatitis 2011; 18(1) doi: 10.1111/j.1365-2893.2010.01283.x
|
| 33 |
Yoshimasa Tokuchi, Goki Suda, Naoki Kawagishi, Masatsugu Ohara, Risako Kohya, Takashi Sasaki, Tomoka Yoda, Osamu Maehara, Shunsuke Ohnishi, Akinori Kubo, Sonoe Yoshida, Qingjie Fu, Zijian Yang, Shunichi Hosoda, Takashi Kitagataya, Kazuharu Suzuki, Masato Nakai, Takuya Sho, Mitsuteru Natsuizaka, Koji Ogawa, Naoya Sakamoto. Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight. Hepatology Research 2023; 53(7) doi: 10.1111/hepr.13899
|
| 34 |
Joost Boeckmans, Matthias Rombaut, Thomas Demuyser, Baptist Declerck, Denis Piérard, Vera Rogiers, Joery De Kock, Luc Waumans, Koen Magerman, Reinoud Cartuyvels, Jean-Luc Rummens, Robim M. Rodrigues, Tamara Vanhaecke. Infections at the nexus of metabolic-associated fatty liver disease. Archives of Toxicology 2021; 95(7) doi: 10.1007/s00204-021-03069-1
|
| 35 |
Timothy J. S. Cross, Mohammed M. Rashid, Philip A. Berry, Phillip M. Harrison. The importance of steatosis in chronic hepatitis C infection and its management: A review. Hepatology Research 2010; 40(3) doi: 10.1111/j.1872-034X.2010.00626.x
|
| 36 |
Francesco Negro. Abnormalities of lipid metabolism in hepatitis C virus infection. Gut 2010; 59(9) doi: 10.1136/gut.2009.192732
|
| 37 |
Gulam H. Syed, Aleem Siddiqui. Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus. Hepatology 2010; 54(6) doi: 10.1002/hep.24619
|
| 38 |
Donna N. Douglas, Christopher Hao Pu, Jamie T. Lewis, Rakesh Bhat, Anwar Anwar-Mohamed, Michael Logan, Garry Lund, William R. Addison, Richard Lehner, Norman M. Kneteman. Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus. Journal of Biological Chemistry 2016; 291(4) doi: 10.1074/jbc.M115.674861
|
| 39 |
Mohamed Shengir, Mohamed Elgara, Giada Sebastiani. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World Journal of Gastroenterology 2021; 27(17): 1959-1972 doi: 10.3748/wjg.v27.i17.1959
|
| 40 |
Matthew S Miller, Joe S Mymryk. An Unhealthy Relationship: Viral Manipulation of the Nuclear Receptor Superfamily. Future Microbiology 2011; 6(9) doi: 10.2217/fmb.11.80
|
| 41 |
Masoud Ghorbani, Turaya Naas, Catalina Soare, Rashmi Kothary, Francisco Diaz-Mitoma. Microarray analysis of gene expression in the liver of transgenic mouse model of HCV infection. Advances in Bioscience and Biotechnology 2012; 3(08) doi: 10.4236/abb.2012.38141
|
| 42 |
Khushboo Irshad, Priyanka Gupta, Mohammad Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305
|
| 43 |
Zoe Raglow, Carly Thoma-Perry, Richard Gilroy, Yu-Jui Yvonne Wan. The interaction between HCV and nuclear receptor-mediated pathways. Pharmacology & Therapeutics 2011; 132(1) doi: 10.1016/j.pharmthera.2011.05.005
|
| 44 |
Naoki Kawagishi, Goki Suda, Akinobu Nakamura, Megumi Kimura, Osamu Maehara, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara, Takaaki Izumi, Machiko Umemura, Masato Nakai, Takuya Sho, Mitsuteru Natsuizaka, Kenichi Morikawa, Koji Ogawa, Yusuke Kudo, Mutsumi Nishida, Hideaki Miyoshi, Naoya Sakamoto, Umberto Vespasiani-Gentilucci. Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis. PLOS ONE 2018; 13(12) doi: 10.1371/journal.pone.0209615
|
| 45 |
Cornelius J. Fernandez, Mohammed Alkhalifah, Hafsa Afsar, Joseph M. Pappachan. Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink. Pathogens 2024; 13(1) doi: 10.3390/pathogens13010068
|
| 46 |
Phumelele Yvonne Siphepho, Yi-Ting Liu, Ciniso Sylvester Shabangu, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Ming-Lung Yu, Shu-Chi Wang. The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments. Biomedicines 2021; 9(10) doi: 10.3390/biomedicines9101491
|
| 47 |
Dowluru S.V.G.K. Kaladhar, Tantravahi Srinivasan. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00005-2
|
| 48 |
Carlos Daniel Bautista-Olivier, Fátima E. Murillo-González, Jorge Limón-Pacheco, Felipe Hernández-Cázares, Selvin Noé Palacios-Rápalo, Carlos Daniel Cordero-Rivera, Carlos Noe Farfan-Morales, Rosa María del Ángel, Guillermo Elizondo. The pregnane X receptor is a novel host target for dengue virus infection that reprograms lipid metabolism and suppresses the immune response. Biochemical Pharmacology 2025; 242 doi: 10.1016/j.bcp.2025.117347
|
| 49 |
Weihua Xu, Zemiao Zhang, Fuxiang Lai, Jiahui Yang, Qiwei Qin, Youhua Huang, Xiaohong Huang. Transcriptome analysis reveals the host immune response upon LMBV infection in largemouth bass (Micropterus salmoides). Fish & Shellfish Immunology 2023; 137 doi: 10.1016/j.fsi.2023.108753
|